Estrogen plus Progestin and the Risk of Coronary Heart Disease

Cited by (1,001)

Items 601–700 of 1,001

1. Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
   Michael W. DeGregorio, Gregory T. Wurz, Chiao-Jung Kao · 2014 · Clinical Interventions in Aging
2. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins
   Michal Vrablı́k, T Fait, Jan Kovář, R. Poledne, R Češka · 2008 · Metabolism
3. Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women
   Irene V. Lambrinoudaki, Areti Augoulea, Eleni Armeni, Demetrios Rizos, A. Alexandrou, Maria G. Creatsa, Maria Vasiliki Kazani, Georgios A. Georgiopoulos, Alexandra Livada, Aimilia Exarchakou et al. · 2011 · Climacteric
4. CADERNOS DE ATENÇÃO BÁSICA
   Mínistério da Saúde · 2006
5. Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor β
   Carola Schubert, Valeria Raparelli, Christina Westphal, Elke Dworatzek, George Petrov, Georgios Kararigas, Vera Regitz‐Zagrosek · 2016 · Biology of Sex Differences
6. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks
   Pratima Gupta, Alison L. Harte, David W Sturdee, A. Sharma, Anthony H Barnett, Sudhesh Kumar, Philip G. McTernan · 2008 · Climacteric
7. Periodontal disease-associated micro-organisms in peri-menopausal and post-menopausal women using or not using hormone replacement therapy. A two-year follow-up study
   Laura Tarkkila, Kirsti Kari, Jussi Oskari Furuholm, Aila E. Tiitinen, Jukka H. Meurman · 2010 · BMC Oral Health
8. Benefits and risks of long-term low-dose oral continuous combined hormone therapy
   Peter H.M. van de Weijer, Lars-Åke Mattsson, Olavi Ylikorkala · 2006 · Maturitas
9. Osteoporosis Medication Use in Nursing Home Patients With Fractures in 1 US State
   Seema Parikh · 2008 · Archives of Internal Medicine
10. State of the Heart: Building Science to Improve Women’s Cardiovascular Health
    Anne G. Rosenfeld · 2006 · American Journal of Critical Care
11. Sex and gender differences in cardiovascular–renal physiology and pathophysiology
    Jane F. Reckelhoff, Christine Maric · 2010 · Steroids
12. Hormone therapy for preventing cardiovascular disease in post-menopausal women
    Caroline Main, Beatrice A. Knight, Tiffany Moxham, Rafael Gabriel Sánchez, Luis María Sánchez-Gómez, Marta Roqué i Figuls, Xavier Bonfill · 2013 · Cochrane Database of Systematic Reviews
13. Bazedoxifene for the prevention of postmenopausal osteoporosis
    Gennari, Luigi · 2008 · Therapeutics and Clinical Risk Management
14. Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
    Ifeyinwa Emmanuela Obiorah, Virgil Craig Jordan · 2013 · Menopause The Journal of The North American Menopause Society
15. Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines
    Elpiniki Rentzeperi, Stavroula Pegiou, Ioannis G. Tsakiridis, Ioannis A Kalogiannidis, Anargyros Kourtis, Apostolos M. Mamopoulos, Apostolos P Athanasiadis, Themistoklis Dagklis · 2023 · Obstetrical & Gynecological Survey
16. Phytoestrogens: food or drug?
    Lucia Bacciottini, Alberto Falchetti, Barbara Pampaloni, Elisa Bartolini, Anna Maria Carossino, Maria Luisa Brandi · 2007 · PubMed Central
17. Protein restriction during pregnancy induces hypertension in adult female rat offspring – influence of oestradiol
    K. Sathishkumar, Rebekah Elkins, Uma Yallampalli, Chandra Yallampalli · 2011 · British Journal Of Nutrition
18. Stellate-ganglion block as a treatment for severe postmenopausal flushing
    Petri van Gastel, J KALLEWAARD, Moniek van der Zanden, Hans de Boer · 2012 · Climacteric
19. Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women
    Barbara A. Frempong, Madia Ricks, Sabyasachi Sen, Anne E. Sumner · 2008 · The Journal of Clinical Endocrinology & Metabolism
20. Effects of Hormone Replacement on Progression of Coronary Calcium as Measured by Electron Beam Tomography
    Matthew Jay Budoff, Race Pei-Wen Chen, Carol J. Hunter, Junichiro Takasu, Nisha Agrawal, Boris Sorochinsky, Songshou Mao · 2005 · Journal of Women s Health
21. Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study
    Judith A. Hsia, Aaron K. Aragaki, Michael J. Bloch, Andrea Z. LaCroix, Robert B. Wallace · 2004 · The American Journal of Cardiology
22. The Impact of the Women's Health Initiative on Discontinuation of Postmenopausal Hormone Therapy: The Minnesota Heart Survey (2000–2002)
    Cheryl A. Barber, Karen L. Margolis, Russell V. Luepker, Donna K. Arnett · 2004 · Journal of Women s Health
23. Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases
    Pedram Honarpisheh, Louise D. McCullough · 2019 · British Journal of Pharmacology
24. Carbon monoxide exposure in the urban environment: An insidious foe for the heart?
    Cyril Reboul, Jérôme Thireau, Grégory Meyer, Lucas André, Philippe Obert, Olivier Cazorla, Sylvain Richard · 2012 · Respiratory Physiology & Neurobiology
25. Design, Synthesis, and Estrogenic Activity of a Novel Estrogen Receptor ModulatorA Hybrid Structure of 17β-Estradiol and Vitamin E in Hippocampal Neurons
    Liqin Zhao, Chunyang Jin, Zisu Mao, Madathil B. Gopinathan, Kenneth S. Rehder, Roberta Dı́az Brinton · 2007 · Journal of Medicinal Chemistry
26. Osteoporosis beliefs and antiresorptive medication use
    Richard R. Cline, Joel F. Farley, Richard A. Hansen, Jon C. Schommer · 2004 · Maturitas
27. Cardiovascular Effects of Noncardiovascular Drugs
    Satish R. Raj, C. Michael Stein, Pablo J. Saavedra, Dan M. Roden · 2009 · Circulation
28. Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease
    Aruna D. Pradhan, Cora Elizabeth Lewis, JoAnn Elisabeth Manson, Jacques E. Rossouw, Susan L. Hendrix, Andrea Z. LaCroix, Paul M. Ridker, Robert D. Langer · 2005 · Thrombosis and Haemostasis
29. Effects of endocrine disorders on lipids and lipoproteins
    Connie B. Newman · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
30. Relationship Between Higher Estradiol Levels and 9‐Year Mortality in Older Women: The Invecchiare in Chianti Study
    Marcello Giuseppe Maggio, Gian Paolo Ceda, Fulvio Lauretani, Stefania Bandinelli, Carmelinda Ruggiero, Jack M. Guralnik, E. Jeffrey Metter, Shari M. Ling, Giuseppe Paolisso, Giorgio Valenti et al. · 2009 · Journal of the American Geriatrics Society
31. Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells
    Tommaso Simoncini, Silvia Garibaldi, Xiaodong Fu, Silvia Pisaneschi, Silvia Begliuomini, Chiara Baldacci, Elena Lenzi, Lorenzo Goglia, Maria Silvia Giretti, Andrea Riccardo Genazzani · 2008 · Menopause The Journal of The North American Menopause Society
32. Tissue-Selective Estrogen Complexes
    David F. Archer · 2010 · Drugs & Aging
33. Impact of hormone therapy for women aged 35 to 65 years, from contraception to hormone replacement
    NATHAN G. KASE · 2009 · Gender Medicine
34. New Perspectives on Mars and Venus: Unravelling the Role of Androgens in Gender Differences in Cardiovascular Biology and Disease
    Martin Ng · 2007 · Heart Lung and Circulation
35. Estradiol gel
    Mark Naunton, Asmar F. Y. Al Hadithy, J. R. B. J. Brouwers, David F. Archer · 2006 · Menopause The Journal of The North American Menopause Society
36. Bone health in systemic lupus erythematosus
    Pantelis Panopalis, Jinoos Yazdany · 2009 · Current Rheumatology Reports
37. Effects of low‐dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes
    A. F. B. Kernohan, Naveed A. Sattar, TE Hilditch, Stephen J. Cleland, MICHAEL P. SMALL, Mary Ann Lumsden, J. M. C. Connell, John R. Petrie · 2006 · Clinical Endocrinology
38. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study
    Peter D. Collins · 2006 · European Heart Journal
39. Osteoporosis in Postmenopausal Women
    Suzanne Sanders, Stephen A. Geraci · 2013 · Southern Medical Journal
40. Sex differences in gene expression in response to ischemia in the human left ventricular myocardium
    Gregory M. Stone, Ashley Choi, Meritxell Oliva, Joshua Gorham, Mahyar Heydarpour, Christine E. Seidman, Jonathan G. Seidman, Sary F. Aranki, Simon C. Body, Vincent J. Carey et al. · 2019 · Human Molecular Genetics
41. Estrogen Treatment Abrogates Neointima Formation in Human C-Reactive Protein Transgenic Mice
    Dajun Wang, Suzanne Oparil, Yiu-Fai Chen, Mark A. McCrory, Gregory A. Skibinski, Wenguang Feng, Alexander J. Szalai · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
42. Shock, terror and controversy: how the media reacted to the Women's Health Initiative
    S. Brown · 2012 · Climacteric
43. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
    2020 · Revista Española de Cardiología (English Edition)
44. Alveolar bone dynamics in osteoporotic rats treated with raloxifene or alendronate: confocal microscopy analysis
    Gabriel Ramalho‐Ferreira, Leonardo Pérez Faverani, Gustavo Augusto Grossi‐Oliveira, Tetuo Okamoto, Roberta Okamoto · 2015 · Journal of Biomedical Optics
45. The role of estrogens in cardiovascular disease in the aftermath of clinical trials
    Lambrini Gouva, Agathocles A. Tsatsoulis · 2004 · HORMONES
46. Guidelines for the hormone treatment of women in the menopausal transition and beyond
    J WRIGHT · 2004 · Maturitas
47. Guidelines for the hormone treatment of women in the menopausal transition and beyondPosition statement by the Executive Committee of the International Menopause Society
    Frederick Nicholas Naftolin, H. P. G. Schneider, I D W Sturdee, M. Birkhäuser, M P Brincat, M Gambacciani, A R Genazzani, K K Limpaphayom, S O'Neil, S Palacios et al. · 2004 · Climacteric
48. Perimenopausal regulation of steroidogenesis in the nonhuman primate
    Krystina G. Sorwell, Steven G. Kohama, Henryk F. Urbanski · 2011 · Neurobiology of Aging
49. Assessing Risks and Benefits of Nonhormonal Treatments for Vasomotor Symptoms in Perimenopausal and Postmenopausal Women
    Holly L. Thacker · 2011 · Journal of Women s Health
50. Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart
    Timothy S. Lancaster, Sarah J. Jefferson, James Craig Hunter, Verónica López, Jennifer E. Van Eyk, Edward G. Lakatta, Donna Hope Korzick · 2012 · Physiological Genomics
51. Exploring Selection Bias by Causal Frailty Models
    Mats Julius Stensrud, Morten Valberg, Kjetil Røysland, Odd O. Aalen · 2017 · Epidemiology
52. Menopausal hormone therapy for primary prevention: why the USPSTF is wrong
    Robert D. Langer, James A. Simon, Amos Pines, Rogerio A. Løbo, Howard Neil Hodis, James H. Pickar, David F. Archer, Philip M. Sarrel, Wulf H. Utian · 2017 · Climacteric
53. The benefit of early survival on PD versus HD—Why this is (still) very important
    Mark Roger Marshall · 2020 · Peritoneal Dialysis International
54. Requirements of a brain selective estrogen: Advances and remaining challenges for developing a NeuroSERM
    Roberta Dı́az Brinton · 2005 · Journal of Alzheimer s Disease
55. Sex hormone levels in patients with sudden cardiac arrest
    Kumar Narayanan, Rasmus J. Havmoeller, Kyndaron Reinier, Katherine Jerger, Carmen Teodorescu, Audrey Uy‐Evanado, Jo Navarro, Adriana Huertas‐Vázquez, Karen Gunson, Jonathan Jui et al. · 2014 · Heart Rhythm
56. Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator
    Patricia L. Gerbarg, Richard P. Brown · 2015 · Phytomedicine
57. Identifying and Implementing Education Practices Supported by Rigorous Evidence: A User Friendly Guide
    Jon Baron · 2004 · The Journal for Vocational Special Needs Education
58. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo‐controlled study
    Marieke O. Verhoeven, Majoie Hemelaar, Marius J. van der Mooren, Peter Kenemans, Tom Teerlink · 2005 · Journal of Internal Medicine
59. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart.
    Howard Neil Hodis · 2008 · Cleveland Clinic Journal of Medicine
60. Vascular Effects of Estrogen and Progestins and Risk of Coronary Artery Disease: Importance of Timing of Estrogen Treatment
    Funda Güngör, İbrahim Kalelioğlu, Abdullah Turfanda · 2008 · Angiology
61. Evaluation of menopausal hormone therapy use in Korea (2002–2013): A nationwide cohort study
    Chan Young Park, Joong-Yeon Lim, Won–Ho Kim, So Young Kim, Hyun‐Young Park · 2021 · Maturitas
62. Sex differences in the coronary vasodilation induced by 17 β‐oestradiol in the isolated perfused heart from spontaneously hypertensive rats
    Roger Lyrio dos Santos, E. B. Marin, Washington Luiz Silva Gonçalves, Nazaré Souza Bissoli, G.R. Abreu, Margareth Ribeiro Moysés · 2010 · Acta Physiologica
63. Controversies regarding hormone therapy: Insights from inflammation and hemostasis
    Kwang Kon Koh, Bo Hyun Yoon · 2006 · Cardiovascular Research
64. Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin–angiotensin system
    Bruno Fabris, Riccardo Candido, Monica Bortoletto, Barbara Toffoli, Stella Bernardi, Marco Stebel, Moreno Bardelli, Lorena Zentilin, Mauro Giacca, Renzo Carretta · 2010 · Journal of Hypertension
65. Age-related differences in cardiac ischemia–reperfusion injury: effects of estrogen deficiency
    Donna Hope Korzick, Timothy S. Lancaster · 2013 · Pflügers Archiv - European Journal of Physiology
66. Recent epidemiological evidence relevant to the clinical management of the menopause
    Samuel Shapiro · 2007 · Climacteric
67. Cytochromes 1A1/1B1- and Catechol-O-Methyltransferase-Derived Metabolites Mediate Estradiol-Induced Antimitogenesis in Human Cardiac Fibroblast
    Raghvendra Krishna Dubey, Edwin Kerry Jackson, Delbert G. Gillespie, Marinella Rosselli, Federica Barchiesi, Andrée Krust, Hansjoerg Keller, Lefteris C. Zacharia, Bruno Imthurn · 2005 · The Journal of Clinical Endocrinology & Metabolism
68. Effects of Estrogen on Cardiovascular Injury in Ovariectomized Female DahlS.Z- Lepr fa /Lepr fa Rats as a New Animal Model of Metabolic Syndrome
    Tamayo Murase, Takuya Hattori, Masafumi Ohtake, Chieko Nakashima, Miwa Takatsu, Toyoaki Murohara, Kohzo Nagata · 2012 · Hypertension
69. Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation
    Nelson Hd, Haney Em, Roger Chou, Tracy Dana, Fu R, Christina Bougatsos · 2010 · Europe PMC (PubMed Central)
70. Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy
    Mary Seed, Robert H. Knopp · 2004 · Current Opinion in Lipidology
71. Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation
    Ross L. Prentice, Lihong Qi · 2006 · Biostatistics
72. Tibolone Activates Nitric Oxide Synthesis in Human Endothelial Cells
    Tommaso Simoncini, Paolo Mannella, Letizia Fornari, Antonella Caruso, G.L. Varone, Silvia Garibaldi, Andrea Riccardo Genazzani · 2004 · The Journal of Clinical Endocrinology & Metabolism
73. Preventing osteoporosis in symptomatic postmenopausal women
    John Christopher Gallagher, Jeffrey P. Levine · 2010 · Menopause The Journal of The North American Menopause Society
74. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes
    Pauliina Tuomikoski, Tomi S. Mikkola, Esa K Hämäläinen, Matti J. Tikkanen, Ursula Turpeinen, Olavi Ylikorkala · 2010 · Menopause The Journal of The North American Menopause Society
75. A mild favorable effect of soy protein with isoflavones on body composition—a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women
    Liu Zm, SC Ho, Y-m Chen, Ho Yp · 2009 · International Journal of Obesity
76. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997
    Kjersti Sletten Bakken, Anne Elise Eggen, Eiliv Lund · 2004 · Acta Obstetricia Et Gynecologica Scandinavica
77. Neuroendocrine changes in sleep apnea
    Brendon John Yee, Peter Xiaoping Liu, Craig L. Phillips, Ronald R. Grunstein · 2004 · Current Opinion in Pulmonary Medicine
78. Emodin promotes the osteogenesis of MC3T3-E1 cells via BMP-9/Smad pathway and exerts a preventive effect in ovariectomized rats
    Xiaojing Chen, Shuang Zhang, Xiaoting Chen, Yan Hu, Jin Wu, Shuyan Chen, Jing Chang, Genfa Wang, Yanhong Gao · 2017 · Acta Biochimica et Biophysica Sinica
79. Menopausal Symptom Management and Prevention Counseling after the Women's Health Initiative among Women Seen in an Internal Medicine Practice
    Mara A. Schonberg, Christina C. Wee · 2005 · Journal of Women s Health
80. Discussion on "Statistical Issues Arising in the Women's Health Initiative"
    Miguel Ángel Hernán, James M. Robins, Luis Alberto García Rodríguez · 2005 · Biometrics
81. Coronary heart disease in menopausal women: Implications of primary and secondary prevention trials of hormones
    Jacques E. Rossouw · 2005 · Maturitas
82. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate α-ENaC and sgk1 expression in renal collecting duct epithelia
    Christie P. Thomas, Kang Z. Liu, Hemender Singh Vats · 2005 · American Journal of Physiology-Renal Physiology
83. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer
    Aman U. Buzdar, Rowan T. Chlebowski, Jack M. Cuzick, Sean Duffy, John Forbes, W. Jonat, Peter M. Ravdin, on Behalf of the International Aromatase Inhibitor Expert Panel · 2006 · Current Medical Research and Opinion
84. Estrogen modulates serotonin effects on vasoconstriction through Src inhibition
    Jae Gon Kim, Young-Eun Leem, Ilmin Kwon, Jong‐Sun Kang, Young Min Bae, Hana Cho · 2018 · Experimental & Molecular Medicine
85. Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases
    Samar H. Gerges, Ayman O.S. El‐Kadi · 2021 · Pharmacology & Therapeutics
86. Transdermal Drug Delivery: Clinical Considerations for the Obstetrician–Gynecologist
    Russell O. Potts, Rogerio A. Løbo · 2005 · Obstetrics and Gynecology
87. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial: a post-mortem
    Karin B. Michels, Walter Churchill Willett · 2008 · Breast Cancer Research and Treatment
88. Effect of Hot Flushes on Vascular Function
    Pauliina Tuomikoski, Pia Ebert, Per‐Henrik Groop, Petri Haapalahti, Hanna Hautamäki, Mats Rönnback, Olavi Ylikorkala, Tomi S. Mikkola · 2009 · Obstetrics and Gynecology
89. Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?
    Sandra J. Lewis · 2007 · American Heart Journal
90. Metabolic surgery for type 2 diabetes
    Cummings, David E · 2012 · Nature Medicine
91. MECHANISMS IN ENDOCRINOLOGY: Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period
    Θεοδώρα Παππά, Maria K Alevizaki · 2012 · European Journal of Endocrinology
92. Membrane-Initiated Estrogen Receptor Signaling Mediates Metabolic Homeostasis via Central Activation of Protein Phosphatase 2A
    Kazutaka Ueda, Eiki Takimoto, Qing Richard Lu, Pang‐Yen Liu, Nobuaki Fukuma, Yusuke Adachi, Ryo Suzuki, Shengpu Chou, Wendy E. Baur, Mark J. Aronovitz et al. · 2018 · Diabetes
93. Coronary Artery Disease in Women: A Comprehensive Appraisal
    Nili Schamroth Pravda, Orith Karny-Rahkovich, Arthur Shiyovich, Miri Schamroth Pravda, Naomi Rapeport, Hana Vaknin Assa, Alon Eisen, Ran Kornowski, Avital Porter · 2021 · Journal of Clinical Medicine
94. Increased Estrogen Receptor β in Adipose Tissue Is Associated With Increased Intracellular and Reduced Circulating Adiponectin Protein Levels in Aged Female Rats
    Nanette J. Tomicek, Timothy S. Lancaster, Donna Hope Korzick · 2011 · Gender Medicine
95. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy
    JoAnn E. Manson · 2012 · Metabolism
96. Understanding the oestrogen action in experimental and clinical atherosclerosis
    Jean‐François Arnal, Victorine Douin‐Echinard, Laurent Brouchet, Florence Trémollières, Henrik Laurell, Françoise Lenfant, Alain‐Pierre Gadeau, Jean‐Charles Guéry, Pierre Gourdy · 2006 · Fundamental and Clinical Pharmacology
97. Estrogen and progestogen therapy in postmenopausal women
    2008 · Fertility and Sterility
98. Pathogenesis of Atherosclerosis
    Dai Yumino, Thomas Douglas Bradley · 2007 · American Journal of Respiratory and Critical Care Medicine
99. Latest US KDOQI Anaemia Guidelines update what are the implications for Europe?
    Iain C. Macdougall, Kai‐Uwe Eckardt, Francesco Locatelli · 2007 · Nephrology Dialysis Transplantation
100. What Is Pharmacoepidemiology?
     Brian L. Strom · 2019 · Pharmacoepidemiology